Next Article in Journal
Elsinopirins A–D, Decalin Polyketides from the Ascomycete Elsinoё pyri
Previous Article in Journal
Acknowledgement to Reviewers of Biomolecules in 2017
Previous Article in Special Issue
Evolutionary Conservation of the Components in the TOR Signaling Pathways
Article Menu

Export Article

Open AccessReview
Biomolecules 2018, 8(1), 7; doi:10.3390/biom8010007

PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer

1
Department of Biomedical Engineering, Dalian University of Technology, Dalian 116024, China
2
State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian 116024, China
3
Center for Translational Medicine, Suizhou Hospital, Hubei University of Medicine, Suizhou 441300, China
*
Authors to whom correspondence should be addressed.
Received: 5 December 2017 / Revised: 25 January 2018 / Accepted: 30 January 2018 / Published: 4 February 2018
(This article belongs to the Special Issue TOR Signaling Pathway)
View Full-Text   |   Download PDF [1055 KB, uploaded 4 February 2018]   |  

Abstract

Ovarian cancer is a medical term that includes a number of tumors with different molecular biology, phenotypes, tumor progression, etiology, and even different diagnosis. Some specific treatments are required to address this heterogeneity of ovarian cancer, thus molecular characterization may provide an important tool for this purpose. On a molecular level, proviral-integration site for Moloney-murine leukemia virus (PIM) kinases are over expressed in ovarian cancer and play a vital role in the regulation of different proteins responsible for this tumorigenesis. Likewise, the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway is also a central regulator of the ovarian cancer. Interestingly, recent research has linked the PIM kinases to the PI3K/AKT/mTOR pathway in several types of cancers, but their connection in ovarian cancer has not been studied yet. Once the exact relationship of PIM kinases with the PI3K/AKT/mTOR pathway is acquired in ovarian cancer, it will hopefully provide effective treatments on a molecular level. This review mainly focuses on the role of PIM kinases in ovarian cancer and their interactions with proteins involved in its progression. In addition, this review suggests a connection between the PIM kinases and the PI3K/AKT/mTOR pathway and their parallel mechanism in the regulation of ovarian cancer. View Full-Text
Keywords: PI3K/AKT/mTOR pathway; BAD; cMyc; CDK1 PI3K/AKT/mTOR pathway; BAD; cMyc; CDK1
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Aziz, A.U.R.; Farid, S.; Qin, K.; Wang, H.; Liu, B. PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer. Biomolecules 2018, 8, 7.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Biomolecules EISSN 2218-273X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top